Third Generation Cephalosporins in the Parenteral to Oral Switch
- 1 January 1994
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 5 (2) , 27-33
- https://doi.org/10.2165/00019053-199400052-00006
Abstract
In the present economic climate, it is increasingly necessary to ensure the cost-effectiveness of all aspects of healthcare. The expenditure on medications in a hospital is largely determined by the workload and throughput, but efforts to rationalise the use of medications will result in benefits both in patient care and overall costs. The purpose of this report is to discuss the advantages of switching from parenteral to oral cephalosporin therapy after the initial stage of infection treatment, the potential of presently available oral cephalosporins for use in a parenteral-to-oral switch regimen, and the outcome of a parenteral-to-oral switch programme, which used parenteral cefotaxime and oral cefixime, implemented at Hillingdon Hospital.Keywords
This publication has 21 references indexed in Scilit:
- Efficacy and Tolerability of Cefixime in Otitis MediaDrugs, 1991
- Cefixime, in-vitro activity, pharmacokinetics and tissue penetrationJournal of Antimicrobial Chemotherapy, 1989
- In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefiximeThe Pediatric Infectious Disease Journal, 1987
- Economic impact of streamlining antibiotic administration.1987
- Antimicrobial Activity of Desacetylcefotaxime Alone and in Combination with Cefotaxime: Evidence of SynergyClinical Infectious Diseases, 1982
- Use of cefotaxime, a β-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organismsThe American Journal of Medicine, 1981
- Bacteremia in the 1980s with special reference to the role of cefotaxime.1981
- Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levelsAntimicrobial Agents and Chemotherapy, 1980
- Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo)Journal of Antimicrobial Chemotherapy, 1980
- Cefotaxime in the treatment of pneumococcal pneumoniaJournal of Antimicrobial Chemotherapy, 1980